Developer docs
API playgroundTry for free, no card

Search company profiles

CIVCO Radiotherapy

Full company profile

uuid000r2ts

Namestring
CIVCO Radiotherapy
Legal namestring
CIVCO Radiotherapy
Websiteurl
civcort.com
Company typeenum
Private
Founded yearint
1982
Descriptiontext

CIVCO Radiotherapy, now operating as CQ Medical, is a US-based medical device company founded in 1982 and headquartered in Orange City, Iowa, specializing in patient positioning and immobilization hardware for radiotherapy and adjacent clinical procedures. The company's core product portfolio spans radiotherapy couchtops and overlays, thermoplastics, vacuum cushions, fiducial markers, brachytherapy applicators and positioning devices, and specialized lines including MRSeries (for MRI-guided radiotherapy) and ProtonSeries (for proton therapy). It also offers patient-specific custom devices through the acquired dot decimal brand, the Symphony integrated imaging-treatment-transfer platform, the Curvaform solution for kyphotic patients, the Alta Multipurpose Device compatible with HexaPOD evo RT, and positioning solutions for upright radiotherapy and veterinary oncology. Non-radiotherapy product lines extend into interventional/cardiology/radiology, neuroradiology, and rhinoplasty.

The company sells primarily to hospitals, cancer centers, radiotherapy clinics, OEMs of linear accelerators and proton/MR-linac systems, veterinary clinics, and providers of low-dose radiation therapy for benign conditions. Revenue is generated through hardware sales via a multi-channel model comprising a direct enterprise field sales force, a global distributor network (Find-a-Distributor portal), OEM partnerships where CIVCO/CQ Medical devices are bundled with radiotherapy equipment, and a corporate e-commerce storefront. Pricing is negotiated and not publicly disclosed. Demand generation is supported by CE-accredited education programs, an extensive clinical resource library, conference participation, and a partnership with the non-profit Radiating Hope.

The company operates as a privately held subsidiary under the CQ Medical brand identity, with 101-250 employees and no disclosed venture capital or public-market backing. Recent strategic activity includes a 2026 rebranding to CQ Medical, the acquisition of dot decimal, multiple new product launches (Curvaform, Alta HexaPOD compatibility, LDRT for osteoarthritis), and global expansion of distributor and OEM channels. No AI/ML capabilities, APIs, or software platforms are present in the product portfolio, which remains focused on physical positioning and workflow integration hardware.

Short descriptiontext

CIVCO Radiotherapy, now CQ Medical, designs and manufactures patient positioning and immobilization devices for radiotherapy, brachytherapy, interventional, neuroradiology, rhinoplasty, and veterinary applications, serving hospitals, cancer centers, OEMs, and veterinary clinics globally through direct sales, distributors, and OEM partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersOrange City, United States
HQ citystring
Orange City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
radiotherapy patient positioning, medical immobilization devices, brachytherapy accessories, radiation therapy equipment, patient positioning systems
Industry1 code
1Contrast Media Injectors & Radiology Accessories
CodeHLAHABAKPrimaryYes
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Radiotherapy Patient Positioning and Immobilization Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Manufacturing and Sales
TypeHardware Sales
Description

CIVCO Radiotherapy generates revenue through the manufacture and sale of patient positioning, immobilization, and radiation therapy accessories. The company sells directly to healthcare providers and through OEM partnerships and distributor networks.

openpr.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

CIVCO Radiotherapy (now operating as CQ Medical) designs and manufactures patient positioning and immobilization devices for radiation therapy. Its portfolio includes couchtops, overlays, thermoplastics, vacuum cushions, fiducial markers, brachytherapy accessories, and specialized product lines for MRI-guided (MRSeries) and proton therapy (ProtonSeries), along with the Symphony patient transfer system and dot decimal custom devices. The company sells to hospitals, cancer centers, radiotherapy clinics, OEMs, and veterinary oncology providers globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • CIVCO Radiotherapy is ranked among 17 leading market players in the ultrasound needle guides market by STATS N DATA research.
Product overview1 text field

CIVCO Radiotherapy (now operating as CQ Medical) is a comprehensive medical device company offering a platform of patient positioning, immobilization, and imaging solutions for radiation therapy, brachytherapy, and interventional procedures. The product portfolio includes radiotherapy-specific offerings (Functional & Low-Dose RT, .decimal Custom Devices acquired brand, Couchtops & Overlays, Symphony Patient Transfer system, SBRT/SRS solutions, MRSeries and ProtonSeries specialized lines, thermoplastics, and specialty devices like the Alta Multipurpose Device and Curvaform), complemented by Brachytherapy, Interventional/Cardiology/Radiology, Neuroradiology, and Rhinoplasty product lines. The portfolio serves cancer treatment centers, hospitals, and veterinary clinics with both standard and patient-specific custom devices.

Product and service1 record
1Radiotherapy Patient Positioning and Immobilization Devices
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CQ Medical (CIVCO Radiotherapy) partners with Radiating Hope, a non-profit organization dedicated to expanding access to radiation therapy in underserved regions globally. The partnership involves charitable support and product contributions to help establish radiotherapy capabilities in resource-limited settings, aligning with the company's mission to expand cancer care access.

Strategic tierCoreTypeTechnology or Integration
Description

CQ Medical acquired dot decimal, a brand known for patient-specific custom radiotherapy devices. The dot decimal product line is now integrated under the CQ Medical / CIVCO Radiotherapy umbrella, enhancing the company's patient-specific device capabilities and custom device offerings for individualized cancer treatment.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

A leading global vendor of radiation therapy equipment (linacs, Gamma Knife, brachytherapy afterloaders) and a broad portfolio of radiation oncology software and accessories. CIVCO competes with Elekta-branded positioning/accessory offerings and, via OEM partnerships, complements Elekta's installed base of treatment systems.

TypeBroad incumbent
Description

Dominant global supplier of linear accelerators, proton therapy systems (ProBeam), and radiation oncology software. Varian/Siemens Healthineers ships integrated patient positioning solutions and is both a competitor for OEM-branded accessories and an OEM partner channel for CIVCO's third-party positioning products.

TypeDirect peer
Description

A direct competitor focused on patient positioning and immobilization devices for radiotherapy, including couchtops, thermoplastic masks, and motion-management systems. Qfix competes most directly with CIVCO's radiotherapy positioning portfolio.

TypeDirect peer
Description

Specialized manufacturer of patient positioning and immobilization products for radiation therapy, overlapping with CIVCO's couchtops, head & neck, and standard radiotherapy positioning categories.

TypeDirect peer
Description

Provides surface-guided radiation therapy (AlignRT) and patient positioning/motion-monitoring solutions used alongside linacs. Vision RT is a complementary competitor in the precision radiotherapy positioning value chain and addresses similar clinical goals to CIVCO's positioning devices.

TypeBroad incumbent
Description

Provides radiation therapy quality assurance, dosimetry, and patient positioning/immobilization products. Sun Nuclear competes with CIVCO in select accessories and shares the same radiation oncology buyer base of physicists and dosimetrists.

TypeBroad incumbent
Description

Offers treatment planning, image-guided radiation therapy software, and select patient positioning solutions for SRS/SRT and linac-based workflows. Brainlab competes with CIVCO for technology-driven positioning and workflow integration in advanced radiotherapy.

TypeBroad incumbent
Description

Pioneer of MR-guided radiation therapy systems (MRIdian) — directly addresses the clinical workflow for which CIVCO's MRSeries product line is specialized. ViewRay/Elekta integration intensifies competitive dynamics around MR-linac positioning accessories.

TypeEmerging player
Description

Patient-specific 3D-printed radiotherapy positioning devices — the original brand acquired by CQ Medical. Now fully under CIVCO, but historically a focused innovator in custom devices for complex treatment plans; relevant as a direct sub-competitor within CIVCO's own portfolio.

10Candor Denmark
TypeDirect peer
Description

European-based manufacturer of radiotherapy patient positioning and immobilization devices, including couchtops, headrests, and breast/hip positioning systems. A direct regional-adjacent peer in CIVCO's core radiotherapy positioning category.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CIVCO Radiotherapy

Radiotherapy Patient Positioning and Immobilization Devicescivcort.com

CIVCO Radiotherapy, now CQ Medical, designs and manufactures patient positioning and immobilization devices for radiotherapy, brachytherapy, interventional, neuroradiology, rhinoplasty, and veterinary applications, serving hospitals, cancer centers, OEMs, and veterinary clinics globally through direct sales, distributors, and OEM partnerships.

What CIVCO Radiotherapy does

CIVCO Radiotherapy, now operating as CQ Medical, is a US-based medical device company founded in 1982 and headquartered in Orange City, Iowa, specializing in patient positioning and immobilization hardware for radiotherapy and adjacent clinical procedures. The company's core product portfolio spans radiotherapy couchtops and overlays, thermoplastics, vacuum cushions, fiducial markers, brachytherapy applicators and positioning devices, and specialized lines including MRSeries (for MRI-guided radiotherapy) and ProtonSeries (for proton therapy). It also offers patient-specific custom devices through the acquired dot decimal brand, the Symphony integrated imaging-treatment-transfer platform, the Curvaform solution for kyphotic patients, the Alta Multipurpose Device compatible with HexaPOD evo RT, and positioning solutions for upright radiotherapy and veterinary oncology. Non-radiotherapy product lines extend into interventional/cardiology/radiology, neuroradiology, and rhinoplasty.

The company sells primarily to hospitals, cancer centers, radiotherapy clinics, OEMs of linear accelerators and proton/MR-linac systems, veterinary clinics, and providers of low-dose radiation therapy for benign conditions. Revenue is generated through hardware sales via a multi-channel model comprising a direct enterprise field sales force, a global distributor network (Find-a-Distributor portal), OEM partnerships where CIVCO/CQ Medical devices are bundled with radiotherapy equipment, and a corporate e-commerce storefront. Pricing is negotiated and not publicly disclosed. Demand generation is supported by CE-accredited education programs, an extensive clinical resource library, conference participation, and a partnership with the non-profit Radiating Hope.

The company operates as a privately held subsidiary under the CQ Medical brand identity, with 101-250 employees and no disclosed venture capital or public-market backing. Recent strategic activity includes a 2026 rebranding to CQ Medical, the acquisition of dot decimal, multiple new product launches (Curvaform, Alta HexaPOD compatibility, LDRT for osteoarthritis), and global expansion of distributor and OEM channels. No AI/ML capabilities, APIs, or software platforms are present in the product portfolio, which remains focused on physical positioning and workflow integration hardware.

CIVCO Radiotherapy firmographics

Firmographics
Name
CIVCO Radiotherapy
Legal name
CIVCO Radiotherapy
Website
https://civcort.com
Company type
Private
Founded year
1982
Operating status
Operating
Headcount range
101–250 employees
Short description
CIVCO Radiotherapy, now CQ Medical, designs and manufactures patient positioning and immobilization devices for radiotherapy, brachytherapy, interventional, neuroradiology, rhinoplasty, and veterinary applications, serving hospitals, cancer centers, OEMs, and veterinary clinics globally through direct sales, distributors, and OEM partnerships.
Ownership category
akta.pro rank

CIVCO Radiotherapy industry classification

Industry
Product category
Radiotherapy Patient Positioning and Immobilization Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Contrast Media Injectors & Radiology Accessories (HLAHABAK)

Keywords

  • Radiotherapy patient positioning
  • Medical immobilization devices
  • Brachytherapy accessories
  • Radiation therapy equipment
  • Patient positioning systems

Where CIVCO Radiotherapy is headquartered

Location

Headquarters

HQ city
Orange City
HQ country
United States
HQ region
North America

Markets served

CIVCO Radiotherapy business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical Device Manufacturing and Sales: CIVCO Radiotherapy generates revenue through the manufacture and sale of patient positioning, immobilization, and radiation therapy accessories. The company sells directly to healthcare providers and through OEM partnerships and distributor networks.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

CIVCO Radiotherapy product offering

Product offering

Core offering

CIVCO Radiotherapy (now operating as CQ Medical) designs and manufactures patient positioning and immobilization devices for radiation therapy. Its portfolio includes couchtops, overlays, thermoplastics, vacuum cushions, fiducial markers, brachytherapy accessories, and specialized product lines for MRI-guided (MRSeries) and proton therapy (ProtonSeries), along with the Symphony patient transfer system and dot decimal custom devices. The company sells to hospitals, cancer centers, radiotherapy clinics, OEMs, and veterinary oncology providers globally.

Product overview

CIVCO Radiotherapy (now operating as CQ Medical) is a comprehensive medical device company offering a platform of patient positioning, immobilization, and imaging solutions for radiation therapy, brachytherapy, and interventional procedures. The product portfolio includes radiotherapy-specific offerings (Functional & Low-Dose RT, .decimal Custom Devices acquired brand, Couchtops & Overlays, Symphony Patient Transfer system, SBRT/SRS solutions, MRSeries and ProtonSeries specialized lines, thermoplastics, and specialty devices like the Alta Multipurpose Device and Curvaform), complemented by Brachytherapy, Interventional/Cardiology/Radiology, Neuroradiology, and Rhinoplasty product lines. The portfolio serves cancer treatment centers, hospitals, and veterinary clinics with both standard and patient-specific custom devices.

Differentiator

Problem solved

Functional benefit

Products and services

  • Radiotherapy Patient Positioning and Immobilization Devices

Quantifiable outcome

  • CIVCO Radiotherapy is ranked among 17 leading market players in the ultrasound needle guides market by STATS N DATA research.

Companies that use CIVCO Radiotherapy

Customer profile

Segments5 records

Ideal customer profiles3 records

CIVCO Radiotherapy technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

CIVCO Radiotherapy partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Radiating HopecoreStrategic or Co-development PartnerCQ Medical (CIVCO Radiotherapy) partners with Radiating Hope, a non-profit organization dedicated to expanding access to radiation therapy in underserved regions globally. The partnership involves charitable support and product contributions to help establish radiotherapy capabilities in resource-limited settings, aligning with the company's mission to expand cancer care access.
  • dot decimal (Acquired Brand/Product Line)coreTechnology or IntegrationCQ Medical acquired dot decimal, a brand known for patient-specific custom radiotherapy devices. The dot decimal product line is now integrated under the CQ Medical / CIVCO Radiotherapy umbrella, enhancing the company's patient-specific device capabilities and custom device offerings for individualized cancer treatment.

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

CIVCO Radiotherapy competitors and assessment

Company assessment

Broad incumbents

  • Elekta: A leading global vendor of radiation therapy equipment (linacs, Gamma Knife, brachytherapy afterloaders) and a broad portfolio of radiation oncology software and accessories. CIVCO competes with Elekta-branded positioning/accessory offerings and, via OEM partnerships, complements Elekta's installed base of treatment systems.
  • Varian Medical Systems (Siemens Healthineers): Dominant global supplier of linear accelerators, proton therapy systems (ProBeam), and radiation oncology software. Varian/Siemens Healthineers ships integrated patient positioning solutions and is both a competitor for OEM-branded accessories and an OEM partner channel for CIVCO's third-party positioning products.
  • Sun Nuclear (Mirion Technologies): Provides radiation therapy quality assurance, dosimetry, and patient positioning/immobilization products. Sun Nuclear competes with CIVCO in select accessories and shares the same radiation oncology buyer base of physicists and dosimetrists.
  • Brainlab: Offers treatment planning, image-guided radiation therapy software, and select patient positioning solutions for SRS/SRT and linac-based workflows. Brainlab competes with CIVCO for technology-driven positioning and workflow integration in advanced radiotherapy.
  • ViewRay (now part of Elekta): Pioneer of MR-guided radiation therapy systems (MRIdian) — directly addresses the clinical workflow for which CIVCO's MRSeries product line is specialized. ViewRay/Elekta integration intensifies competitive dynamics around MR-linac positioning accessories.

Direct peers

  • Qfix: A direct competitor focused on patient positioning and immobilization devices for radiotherapy, including couchtops, thermoplastic masks, and motion-management systems. Qfix competes most directly with CIVCO's radiotherapy positioning portfolio.
  • Bionix Radiation Therapy: Specialized manufacturer of patient positioning and immobilization products for radiation therapy, overlapping with CIVCO's couchtops, head & neck, and standard radiotherapy positioning categories.
  • Vision RT: Provides surface-guided radiation therapy (AlignRT) and patient positioning/motion-monitoring solutions used alongside linacs. Vision RT is a complementary competitor in the precision radiotherapy positioning value chain and addresses similar clinical goals to CIVCO's positioning devices.
  • Candor Denmark: European-based manufacturer of radiotherapy patient positioning and immobilization devices, including couchtops, headrests, and breast/hip positioning systems. A direct regional-adjacent peer in CIVCO's core radiotherapy positioning category.

Emerging players

  • .decimal: Patient-specific 3D-printed radiotherapy positioning devices — the original brand acquired by CQ Medical. Now fully under CIVCO, but historically a focused innovator in custom devices for complex treatment plans; relevant as a direct sub-competitor within CIVCO's own portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

CIVCO Radiotherapy social profiles

Digital presence

CIVCO Radiotherapy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CIVCO Radiotherapy leadership team

Management profile

Number of profiles

Profiles1 record

CIVCO Radiotherapy funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CIVCO Radiotherapy M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CIVCO Radiotherapy

What does CIVCO Radiotherapy do?

CIVCO Radiotherapy (now operating as CQ Medical) designs and manufactures patient positioning and immobilization devices for radiation therapy. Its portfolio includes couchtops, overlays, thermoplastics, vacuum cushions, fiducial markers, brachytherapy accessories, and specialized product lines for MRI-guided (MRSeries) and proton therapy (ProtonSeries), along with the Symphony patient transfer system and dot decimal custom devices. The company sells to hospitals, cancer centers, radiotherapy clinics, OEMs, and veterinary oncology providers globally.

Is CIVCO Radiotherapy a public or private company?

CIVCO Radiotherapy is a private company. It is classified as corporate owned and is currently operating.

When was CIVCO Radiotherapy founded?

CIVCO Radiotherapy was founded in 1982. It employs 101 to 250 people.

Where is CIVCO Radiotherapy based?

CIVCO Radiotherapy is headquartered in Orange City, United States, in the North America region.

How does CIVCO Radiotherapy make money?

One revenue line is on record: medical Device Manufacturing and Sales.

Who are CIVCO Radiotherapy's main competitors?

Broad incumbents on record are Elekta, Varian Medical Systems (Siemens Healthineers), Sun Nuclear (Mirion Technologies), Brainlab and ViewRay (now part of Elekta). Direct peers are Qfix, Bionix Radiation Therapy, Vision RT and Candor Denmark. .decimal is listed as an emerging player.

Does CIVCO Radiotherapy have an API?

No public API is recorded for CIVCO Radiotherapy.

What industry is CIVCO Radiotherapy in?

CIVCO Radiotherapy's product category is Radiotherapy Patient Positioning and Immobilization Devices. Its primary akta.pro industry code is HLAHABAK, Contrast Media Injectors & Radiology Accessories. Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comFuture of Ultrasound Needle Guides Market: Analysis Led by CIVCO Radiotherapy, Aspen Surgical, FUJIFILM, Siemens Healthineers, BD, Argon Medical Devices, Hologic, Inc.STATS N DATA published a market research report analyzing the ultrasound needle guides market, identifying it as a sector experiencing significant growth driven by increasing adoption of ultrasound-guided procedures across clinical settings. The report highlights key growth drivers including sustainability trends favoring reusable needle guides, digitalization, and integration of artificial intelligence into needle guidance technology, while noting challenges such as regulatory hurdles and supply chain gaps. The competitive landscape sections profiles 17 companies including CIVCO Radiotherapy, Aspen Surgical, FUJIFILM, Siemens Healthineers, BD, Argon Medical Devices, and Hologic among the leading market players.PR NewswireCIVCO Radiotherapy and Qfix Launch CQ Medical BrandCIVCO Radiotherapy and Qfix have launched a new consolidated brand, CQ Medical, combining their more than 80 years of combined experience in radiotherapy and cancer therapy solutions. Mike Sutter has been named permanent CEO, and the company has simultaneously acquired Nanovi A/S, a Danish precision marking company for radiation therapy, and Advaray, a U.S. hydrogel device developer for pelvic brachytherapy. The rebranding completes the integration of the two companies that merged in October 2022 under private equity ownership.PR NewswireGlobal Radiotherapy Leaders CIVCO-RT and Qfix Tap LUDWIG+ as Creative Agency of RecordWoman-owned advertising agency LUDWIG+ has been selected as creative agency of record to lead the rebrand of CIVCO Radiotherapy and Qfix, two recently merged radiotherapy companies. CIVCO RT, a Blue Wolf Capital portfolio company, acquired Qfix with the goal of uniting to become the global leader in the medical positioning innovation market. The new combined brand will be unveiled at the ASTRO conference in October 2023, with the full-spectrum campaign spanning advertising, trade shows, social media, digital, and print channels.PR NewswireCIVCO Radiotherapy and Qfix Showcase as One Company at ESTRO 2023CIVCO Radiotherapy and Qfix, now operating as a unified company, are exhibiting their radiotherapy patient immobilization and positioning solutions at the ESTRO Congress 2023 in Vienna, Austria from May 12-16. The combined entity will showcase products including the Encompass SRS Immobilization System, the Symphony Patient Transfer System, and various breastboards and proton solutions at booth #200. Dr. André Miranda Pires from the Institute Português de Oncologia do Porto will present clinical research on the Comfort Marker 2.0 patient marking system during the congress.PR NewswireCIVCO Radiotherapy to Exhibit Most Recent Innovations at ASTRO Annual MeetingCIVCO Radiotherapy, a provider of radiotherapy solutions, announced it will exhibit its TotalRT All in One Solution along with other innovations at the ASTRO Annual Meeting in San Antonio, Texas from October 23-25, 2022. The company will showcase products including the Evolve Breastboard, Pediatric ProForm Head & Neck Solution, and Comfort Marker 2.0 Patient Marking System at booth #3766. The announcement highlights collaborative partnerships with Chabner XRT and GrayDuck, while noting that CIVCO Radiotherapy celebrates 40 years of operations in 2022.PR NewswireCIVCO Radiotherapy to Feature TotalRT All in One Solution at AAPM Annual MeetingCIVCO Radiotherapy announced it will showcase its TotalRT All in One Solution along with several innovations at the AAPM Annual Meeting in Washington, D.C. from July 10-14, 2022. The company will display new products including a Pediatric ProForm Head & Neck Solution designed specifically for pediatric proton therapy, the Solstice SRS Immobilization System, and the Body Pro-Lok ONE SBRT Immobilization System. CIVCO Radiotherapy is also highlighting collaborative partner solutions including the Medical Precision Comfort Marker 2.0, Chabner XRT Radiation Bra, and GrayDuck oral positioning stents.PR NewswireCIVCO Radiotherapy to Unveil TotalRT All in One Solution at ESTRO 2022CIVCO Radiotherapy announced the unveiling of their TotalRT All in One Solution at the ESTRO Congress in Copenhagen, Denmark from May 6-10, 2022. The TotalRT Platform is designed to adapt positioning and immobilization solutions for radiotherapy clinical setup and treatment needs, featuring a large artifact-free treatment area for precise dose delivery and repeatable patient positioning across CT, MR and photon treatment tables. The company will also showcase additional innovations including the Evolve Breastboard, Pro Wing Board, and Pediatric ProForm Head & Neck Solution at the conference.Business Wire BlogBlue Wolf Capital to Acquire CIVCO Radiotherapy from Roper TechnologiesBlue Wolf Capital Partners LLC has entered into an agreement to acquire CIVCO Radiotherapy from Roper Technologies, Inc., with the transaction expected to close by the end of the year. CIVCO Radiotherapy is a global manufacturer of radiotherapy patient positioning equipment headquartered in Iowa. The financial terms of the acquisition were not disclosed.BioSpaceBlue Wolf Capital to Acquire CIVCO Radiotherapy from Roper TechnologiesBlue Wolf Capital Partners LLC has entered into an agreement to acquire CIVCO Radiotherapy from Roper Technologies, Inc. The transaction involves the purchase of the global leader in radiotherapy patient positioning and immobilization equipment, with closing expected by the end of the year. Terms of the deal were not disclosed.PR Newswire$ 779 Million Growth in Radiosurgery and Radiotherapy Robotics Market 2021-2025 | Featuring Key Vendors Including Brainlab AG and CIVCO Radiotherapy among others | TechnavioTechnavio released a market research report projecting the global radiosurgery and radiotherapy robotics market to grow by USD 779.01 million during 2021-2025, progressing at a compound annual growth rate of 5%. The growth is driven by increasing cancer cases, retreatments, and rising demand for non-invasive treatment options, with North America expected to witness the highest regional growth due to improved healthcare quality and focus on innovative technologies. The report identifies five major companies operating in this market segment: Accuray Inc., Best Medical International Inc., Brainlab AG, CIVCO Radiotherapy, and Elekta AB.